Stroke in hemodialysis patients and its association with CHA2DS2-VASC and HAS-BLED scores: a retrospective study
- PMID: 36865009
- PMCID: PMC9972838
- DOI: 10.1093/ckj/sfac260
Stroke in hemodialysis patients and its association with CHA2DS2-VASC and HAS-BLED scores: a retrospective study
Abstract
Background: In the general population, the CHA2DS2-VASC and the HAS-BLED scores are helpful to predict cerebrovascular events and hemorrhage in patients with atrial fibrillation (AF). However, their predictive value remains controversial in the dialysis population. This study aims to explore the association between these scores and cerebral cardiovascular events in hemodialysis (HD) patients.
Methods: This is a retrospective study including all HD patients treated between January 2010 and December 2019 in two Lebanese dialysis facilities. Exclusion criteria are patients younger than 18 years old and patients with a dialysis vintage less than 6 months.
Results: A total of 256 patients were included (66.8% men; mean age 69.3 ± 13.9 years). The CHA2DS2-VASc score was significantly higher in patients with stroke (P = .043). Interestingly, this difference was significant in patients without AF (P = .017). Using receiver operating curve analysis, CHA2DS2-VASc score had an area under the curve (AUC) of 0.628 [95% confidence interval (CI): 0.539-0.718) and the best cut-off value for this score was 4. The HAS-BLED score was also significantly higher in patients with a hemorrhagic event (P < .001). AUC for HAS-BLED score was 0.756 (95% CI: 0.686-0.825) and the best cut-off value was also 4.
Conclusions: In HD patients, CHA2DS2-VASc score can be associated with stroke and HAS-BLED score can be associated with hemorrhagic events even in patients without AF. Patients with a CHA2DS2-VASc score ≥4 are at the highest risk for stroke and adverse cardiovascular outcomes, and those with a HAS-BLED score ≥4 are at the highest risk for bleeding.
Keywords: CHA2DS2-VASc; HAS-BLED; atrial fibrillation; chronic hemodialysis; stroke.
© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.
Figures
Similar articles
-
Cardiovascular Events and Mortality in Patients on Hemodialysis: The Prognostic Value of the CHA2DS2-VASc Score.Medicina (Kaunas). 2024 Jan 12;60(1):144. doi: 10.3390/medicina60010144. Medicina (Kaunas). 2024. PMID: 38256404 Free PMC article.
-
Performance of CHA2DS2-VASc and HAS-BLED in predicting stroke and bleeding in atrial fibrillation and cancer.Eur Heart J Open. 2024 Jun 26;4(4):oeae053. doi: 10.1093/ehjopen/oeae053. eCollection 2024 Jul. Eur Heart J Open. 2024. PMID: 38988675 Free PMC article.
-
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18. J Am Coll Cardiol. 2013. PMID: 24055744
-
Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2021 Nov 22;8:757087. doi: 10.3389/fcvm.2021.757087. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34881309 Free PMC article.
-
CHA2DS2-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting.Turk J Med Sci. 2022 Aug;52(4):1103-1110. doi: 10.55730/1300-0144.5413. Epub 2022 Aug 10. Turk J Med Sci. 2022. PMID: 36326398 Free PMC article. Review.
Cited by
-
Cardiovascular Events and Mortality in Patients on Hemodialysis: The Prognostic Value of the CHA2DS2-VASc Score.Medicina (Kaunas). 2024 Jan 12;60(1):144. doi: 10.3390/medicina60010144. Medicina (Kaunas). 2024. PMID: 38256404 Free PMC article.
-
Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation.Nephrol Dial Transplant. 2024 Jul 31;39(8):1248-1257. doi: 10.1093/ndt/gfae121. Nephrol Dial Transplant. 2024. PMID: 38816212 Free PMC article. Review.
-
Prediction models for ischemic stroke and bleeding in dialysis patients: a systematic review and meta-analysis.Clin Kidney J. 2024 Nov 15;17(12):sfae347. doi: 10.1093/ckj/sfae347. eCollection 2024 Dec. Clin Kidney J. 2024. PMID: 39981320 Free PMC article.
References
-
- USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: US Renal Data System, 2006n.d.
-
- Delanaye P, Bouquegneau A, Dubois Eet al. Fibrillation auriculaire et anticoagulation chez le patient hémodialysé: une decision difficile. Nephrol Ther 2017;13:9–66. - PubMed
LinkOut - more resources
Full Text Sources